His research into dopamine led to the mainstay treatment still used today to treat millions of people with Parkinson’s.
Read: New York Times
His research into dopamine led to the mainstay treatment still used today to treat millions of people with Parkinson’s.
Read: New York Times
The American Parkinson Disease Association (APDA) recently shared the top three questions they are … [Read More...]
From the American Parkinson Disease Association, Northwest Chapter (APDA NW), Tuesday, September … [Read More...]
The two-day APDA Virtual Parkinson’s Conference: Educate, Empower, Engage will be geared towards … [Read More...]